Src Homology 2–Containing Inositol 5′-Phosphatase 1 Negatively Regulates IFN-γ Production by Natural Killer Cells Stimulated with Antibody-Coated Tumor Cells and Interleukin-12
- 1 October 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (19) , 9099-9107
- https://doi.org/10.1158/0008-5472.can-04-4424
Abstract
We have previously shown that natural killer (NK) cells secrete a distinct profile of immunomodulatory cytokines in response to dual stimulation with antibody-coated tumor cells and interleukin-12 (IL-12). This NK cell cytokine response is dependent on synergistic signals mediated by the activating receptor for the Fc portion of IgG (FcγRIIIa) and the IL-12 receptor (IL-12R), both constitutively expressed on NK cells. The phosphatase Src homology 2–containing inositol 5′-phosphatase 1 (SHIP1) is known to exert inhibitory effects on Fc receptor (FcR) signaling via its enzymatic activity on phosphatidylinositol 3-kinase (PI3-K) products within many cells of the immune system, most notably mast cells, B cells, and monocytes. However, its activity in the context of FcR activation on NK cells has not been fully explored. The current study focused on the regulation of FcγRIIIa-induced NK cell cytokine production by SHIP1. Inhibitor studies showed that NK cell IFN-γ production following FcR stimulation in the presence of IL-12 depended, in part, on the downstream products of PI3-K. Overexpression of wild-type (WT) SHIP1, but not a catalytic-deficient mutant, via retroviral transfection of primary human NK cells, resulted in a >70% reduction of NK cell IFN-γ production in response to costimulation. In addition, NK cells from SHIP1−/− mice produced 10-fold greater amounts of IFN-γ following culture with antibody-coated tumor cells plus IL-12 compared with NK cells from WT mice. Further, activation of the mitogen-activated protein kinase (MAPK) family member extracellular signal-regulated kinase (Erk; a downstream target of PI3-K) was significantly enhanced within SHIP1−/− NK cells compared with WT NK cells following costimulation. Pharmacologic inhibition of Erk activity, but not Jnk MAPK activity, led to significantly decreased IFN-γ production from both SHIP1−/− and WT NK cells under these conditions. These results are the first to show a physiologic role for SHIP1 in the regulation of NK cell cytokine production and implicate PI3-K in the induction of MAPK signal transduction following costimulation of NK cells via the FcR and the IL-12R.Keywords
This publication has 42 references indexed in Scilit:
- Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulationBlood, 2005
- A Phase I Study of Interleukin 12 with Trastuzumab in Patients with Human Epidermal Growth Factor Receptor-2-Overexpressing MalignanciesClinical Cancer Research, 2004
- Inhibition of the Jun N-Terminal Protein Kinase Pathway by SHIP-1, a Lipid Phosphatase That Interacts with the Adaptor Molecule Dok-3Molecular and Cellular Biology, 2004
- SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cellsBlood, 2002
- Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2 /neu-positive breast cancer cellsEuropean Journal of Immunology, 2001
- Ig-binding Receptors on Human NK Cells as Effector and Regulatory Surface MoleculesInternational Reviews of Immunology, 2001
- ERKs and p38 Kinases Mediate Ultraviolet B-induced Phosphorylation of Histone H3 at Serine 10Journal of Biological Chemistry, 2000
- Enzymatic Activity of the Src Homology 2 Domain-containing Inositol Phosphatase Is Regulated by a Plasma Membrane LocationJournal of Biological Chemistry, 2000
- Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.The Journal of Experimental Medicine, 1994
- Phosphatidylinositol-3 kinase activation induced upon Fc gamma RIIIA-ligand interaction.The Journal of Experimental Medicine, 1994